INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

Search

Biotage AB

Open

140.6 -0.64

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

140.1

Max

141.5

Schlüsselkennzahlen

By Trading Economics

Einkommen

97M

158M

Verkäufe

92M

582M

KGV

Branchendurchschnitt

25.507

20.525

EPS

1.416

Dividendenrendite

1.82

Gewinnspanne

27.148

Angestellte

680

EBITDA

111M

222M

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.82%

4.36%

Nächstes Ergebnis

16. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-3.9B

7.2B

Vorheriger Eröffnungskurs

141.24

Vorheriger Schlusskurs

140.6

Biotage AB Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Apr. 2025, 06:50 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22. Apr. 2025, 06:04 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22. Apr. 2025, 06:03 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Biotage Board Recommends Shareholders Accept Offer

22. Apr. 2025, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Offer Values Biotage at SEK11.61B

22. Apr. 2025, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Makes SEK145 a Share Bid For Biotage

Peer-Vergleich

Kursveränderung

Biotage AB Prognose

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.